From December 23, 2020 through December 31, 2020, the OIG issued several advisory opinions. The advisory opinions analyzed (1) a program for a pharmaceutical manufacturer to provide financial assistance to certain patients,...more
1/8/2021
/ Advisory Opinions ,
Anti-Kickback Statute ,
Financial Assistance Policies ,
Food and Drug Administration (FDA) ,
Home Health Agencies ,
Manufacturers ,
Medicare ,
OIG ,
Pharmaceutical Industry ,
Prescription Drugs ,
Preventive Health Care ,
REMS ,
Skilled Nursing Facility